Genetic testing company 23andMe (ME) has won court approval to sell its most valuable asset, customer DNA data, despite growing concerns over

Me says any buyer must comply with its consumer privacy policy, but there's no telling who will buy the company and the DNA data it's collected on 15 million people.

The genetic testing firm won permission from a judge to try to sell information about customers’ medical and ancestry-related data, a trove that is considered the most valuable asset in the